Observational prospective study describing the global patient care and follow-up of prostate cancer patients treated with Degarelix (DUO study (Dialogue in Uro-Oncology))

20/06/2017
02/04/2024
EU PAS number:
EUPAS18906
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

This study is an observational, longitudinal, pharmaco-epidemiological, multicenter, prospective cohort study.
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No